A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer c
A study of a personalized vaccine combined with an existing immunotherapy found the treatment helped patients with melanoma avoid cancer recurrence. The combination trains the patient's immune system to go after cancer cells. NPR does not offer or accept money for coverage or interviews.
Anyone who makes such an offer or request is not an NPR employee and does not represent NPR.
Extract — continue reading at the source.
Similar stories
6 outlets
See how this story developed, hour by hour
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
marketwatch.com
21.10.2026
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
arstechnica.com
23.10.2026
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
nytimes.com
22.10.2026
Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial
nbcnews.com
23.10.2026
World first personalised cancer vaccine stops disease returning in major trial
bbc.co.uk
23.10.2026
Moderna shares sink after leaked cancer data missed expectations
ft.com
22.10.2026
Related stories
Fitness became an addiction that left me anxious and sleep deprived
The Top Supplements for Women in Every Decade of Life, According to Experts
I Tried Gap x Victoria Beckham’s New Drop, and My Fall/Winter Outfits Are Set—Shop It Now While Things Are Still in Stock
A DJ Turned Grand Teton National Park Into His Own Personal Set. People Aren’t Happy.
What’s Going on Between Joan Smalls and Candice Swanepoel? Breaking Down the Alleged “Backstabber” Drama
42 Best Christmas Gifts for Everyone On Your List